Stricter Limits for Hydrocodone Pain Pills Backed by FDA Panel

Hydrocodone painkillers, the most popular pharmacy drugs in the U.S., should be placed under greater regulatory restrictions because of the potential for abuse, a panel of advisers to the Food and Drug Administration recommended.

The FDA should expand limits on hydrocodone-combination pills such as Vicodin as well as cough suppressants containing hydrocodone, the advisory committee voted 19-10 today to conclude a two-day meeting in Silver Spring, Maryland. The FDA, which in 2008 denied a request by the Drug Enforcement Administration for stricter regulation, must now decide whether to follow the panel’s recommendation.

Before it's here, it's on the Bloomberg Terminal.